Illumina

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. 

CEO
Jacob Thaysen
CEOJacob Thaysen
Employees
10,370
Employees10,370
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1998
Founded1998
Employees
10,370
Employees10,370

ILMN Key Statistics

Market cap
20.68B
Market cap20.68B
Price-Earnings ratio
30.32
Price-Earnings ratio30.32
Dividend yield
Dividend yield
Average volume
1.81M
Average volume1.81M
High today
$136.54
High today$136.54
Low today
$132.93
Low today$132.93
Open price
$135.65
Open price$135.65
Volume
581.02K
Volume581.02K
52 Week high
$153.06
52 Week high$153.06
52 Week low
$68.70
52 Week low$68.70

Stock Snapshot

With a market cap of 20.68B, Illumina(ILMN) trades at $135.32. The stock has a price-to-earnings ratio of 30.32.

On 2025-12-25, Illumina(ILMN) stock traded between a low of $132.93 and a high of $136.54. Shares are currently priced at $135.32, which is +1.8% above the low and -0.9% below the high.

The Illumina(ILMN)'s current trading volume is 581.02K, compared to an average daily volume of 1.81M.

During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $153.06 at its peak.

During the past year, Illumina(ILMN) stock moved between $68.70 at its lowest and $153.06 at its peak.

ILMN News

TipRanks 3d
Illumina price target raised to $130 from $112 at Canaccord

Canaccord analyst Kyle Mikson raised the firm’s price target on Illumina (ILMN) to $130 from $112 and keeps a Hold rating on the shares. The firm previewed its...

Simply Wall St 4d
What Illumina's MyOme AI Genomics Partnership Means For Shareholders

In December 2025, MyOme announced a collaboration and investment from Illumina to support its Proactive Health Trial, which will test whole-genome sequencing co...

What Illumina's MyOme AI Genomics Partnership Means For Shareholders

Analyst ratings

43%

of 23 ratings
Buy
39.1%
Hold
43.5%
Sell
17.4%

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.